Epidemiology of the myelodysplastic syndromes

The Myelodysplastic Syndromes: Pathobiology and Clinical Management

Volumn , Issue , 2002, Pages 15-28

  Hamblin, Terry J ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85041592709     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. 9th ed. Geneva: World Health Organization, 1977.
2. Reizenstein P, Dabrowski L. Increasing prevalence of the myelodysplastic syndrome. An international Delphi study. Anticancer Res 1991; 11:1069-1070.
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36:69-86.
4. Fernandez-Ferrero S, Ramos F. Dyshaemopoietic bone marrow features in healthy subjects are related to age. Leuk Res 2001; 25:187-189.
5. Jacobs A. Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia. Leukemia 1991; 5:277-282.
6. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996; 88:59-65.
7. Cachia PG, Taylor C, Thompson PW, Tennant GB, Masters G, Pettersson T, Whittaker JA, Burnett AK, Jacobs A, Padua RA. Non-dysplastic myelodysplasia. Leukemia 1994; 8:677-681.
8. Linman JW, Bagby GC, Jr. The preleukemic syndrome (hemopoietic dysplasia) (review). Cancer 1978; 42(suppl 2):854-864.
9. Cartwright RA, Alexander FE, McKinney PA, Ricketts TJ. Leukaemias and Lymphoma: an atlas of distribution within areas of England and Wales 1984-1988. London: Leukaemia Research Fund, 1990:32-40.
10. Cartwright RA, McNally RJQ, Rowland DJ, Thomas J. The Descriptive Epidemiology of Leukaemia and Related Conditions in Parts of the United Kingdom 19841993. London: Leukaemia Research Fund, 1997:9-100.
11. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992; 82:358-367.
12. Radlund A, Thiede T, Hansen S, Carlsson M, Engquist L. incidence of myelodys-plastic syndromes in a Swedish population. Eur J Haematol 1995; 54:153-156.
13. Mayanadie M, Verret C, Moskovtchenko P, Mugneret F, Petrella T, Caillot D, Carli PM. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Br J Cancer 1996; 74:288-290.
14. Bauduer F, Ducout L, Dastugue N, Capdupuy C, Renoux M. Epidemiology of my-elodysplastic syndromes in a French general hospital of the Basque country. Leuk Res 1998; 22:205-208.
15. Shimizu H, Matsushita Y, Aoki K, Nomura T, Yoshida Y, Mizogushi H. Prevalence of myelodysplastic syndromes in Japan. Int J Hematol 1995; 61:17-22.
16. Williamson PJ, Kruger AR, Reynolds PJ, Hamblin TJ, Oscier DG. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 1994; 87:743-745.
17. Phillips MJ, Cull GM, Ewings M. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 1994; 88:896-897.
18. Aul C, Germing U, Gattermann N, Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 1998; 22:93-100.
19. Beloosesky Y, Cohen AM, Grosman B, Grinblat J. Prevalence and survival in myelo-dysplastic syndrome of the refractory anemia type in hospitalized cognitively different geriatric patients. Gerontology 2000; 46:323-327.
20. Emanuel PD. Myelodysplasia and myeloproliferative disorders in childhood: an update. Br J Haematol 1999; 105:852-863.
21. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG. Distinctive demography, biology and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children’s Cancer Group Studies 2681 and 2891. Blood 1998; 91:608-615.
22. de Planque MM, Kluin-Nelemans HC, van Krieken HJ, Kluin PM, Brand A, Bever-stock GC, Willemze R, van Rood JJ. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 1988; 70:5562.
23. Ishihara S, Nakakuma H, Kawaguchi T, Nagakura S, Horikawa K, Hidaka M, Asou N, Mitsuya H. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia. Int J Hematol 2000; 72:206-209.
24. Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA, Gungor T. Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis (review). Eur J Pediatr 1999; 158:995-1000.
25. Bertola DR, Sugayama SM, Albano LM, Kim CA, Gonzalez CH. Noonan syndrome: a clinical and genetic study of 31 patients. Rev Hosp Clin Fac Med Sao Paulo 1999; 54:147-150.
26. Stratton RF, Dobyns WB, Airhart SD, Ledbetter DH. New chromosomal syndrome: Miller-Dieker syndrome and monosomy 17p13. Hum Genet 1984; 67:193-200.
27. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, Shannon KM. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998; 92:267-272.
28. Alter BP. Inherited bone marrow failure syndromes. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott Company, 1995:227-291.
29. Dokal I. Dyskeratosis congenita in all its forms (review). Br J Haematol 2000; 110: 768-779.
30. Kostmann R. Infantile genetic agranulocytosis: a new recessive lethal disease in man. Acta Paediatr Scand 1956; 45:1-12.
31. Passmore SJ, Hann IM, Stilier CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessels JM. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85:1742-1750.
32. Grimwade DJ, Stephenson J, De Silva C, Dalton RG, Mufti GJ. Familial MDS with 5q-abnormality. Br J Haematol 1993; 84:536-538.
33. Kardos G, Veerman AJ, de Waal FC, van Oudheusden LJ, Slater R. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome. Med Pediatr Oncol 1996; 26:54-56.
34. Luna-Fineman S, Shannon KM, Atwater SK, Davis J, Masterson M, Ortega J, Sanders J, Steinherz P, Wienberg V, Lange BJ. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999; 93:459-466.
35. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia 1995; 9:1569-1572.
36. Lucas GS, West RR, Jacobs A. Familial myelodysplasia. Br Med J 1989; 299:551.
37. Olopade OI, Roulston D, Baker T, Narvid S, Le Beau MM, Freireich EJ, Larson RA, Golomb HM. Familial myeloid leukemia associated with the loss of the long arm of chromosome 5. Leukemia 1996; 10:669-674.
38. Wakita A, Komatsu H, Banno S, Ando M, Nitta M, Takada K, Mitimo Y, Ueda R. Myelodysplastic syndrome developed in a mother and her son whose bone marrow karyotype showed monosomy 7. Rinsho Ketsueki 1996; 37:311-316 [Japanese].
39. Kardos G, Veerman AJ, de Waal FC, van Oudheusden LJ, Slater R. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome. Med Pediatr Oncol 1996; 26:54-56.
40. Gao Q, Horwitz M, Roulston D, Hagos F, Zhao N, Freireich EJ, Golomb HM, Olopade OI. Susceptibility gene for familial acute myeloid leukaemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q. Genes Chromosomes Cancer 2000; 28:264-272.
41. Kumar T, Mandla SG, Greer WL. Familial myelodysplastic syndrome with early age of onset. Am J Hematol 2000; 64:53-58.
42. Mandla SG, Goobie S, Kumar RT, Hayne O, Zayed E, Guernsey DL, Greer WL. Genetic analysis of familial myelodysplastic syndrome: absence of linkage to chromosomes 5q31 and 7q22. Cancer Genet Cytogenet 1998; 106:113-118.
43. Hiraga H, Yabe H, Nagai K, Nakayama S. Myelodysplastic syndrome in a patient with familial Pelger-Huet anomaly. Rinsho Ketsueki 1991; 32:1453-1457 [Japanese].
44. Davies SM, Robison LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children’s Cancer Group study. Cancer Epidemiol Biomarkers Prev 2000; 9:563-566.
45. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndrome in individuals with glutathione trans ferase theta 1 (GSTT1) gene defect. Lancet 1996; 347:295-297.
46. Shpilberg O, Dorman JS, Shahar A, Kuller LH. Molecular epidemiology of hematological neoplasms—present status and future directions (review). Leuk Res 1997; 21:265-284.
47. Sbrana I, Musio A. Enhanced expression of common fragile site with occupational exposure to pesticides. Cancer Genet Cytogenet 1995; 82:123-127.
48. Moreland HS. The occurrence of malignancy in radioactive persons. Am J Cancer 1931; 15:2435-2516.
49. Hamilton-Paterson JL. Pre-leukaemic anaemia. Acta Haematol 1949; 2:307-316.
50. Evans RD. The effects of skeletally deposited alpha-ray emitters in man. Br J Radiol 1966; 39:881-895.
51. Finch SC, Hoshino T, Lamphere JP, Ishimaru T. Peripheral blood changes preceding the development of leukemia in atom bomb survivors in Hiroshima and Nagasaki. In: Seno S, Takaku F, Irino S, eds. Topics in Haematology, 16th International Congress of Haematology. Amsterdam: Exerpta Medica, 1977:97-98.
52. Browning E. Toxicity and Metabolism of Industrial Solvents. Amsterdam: Elsevier, 1965:3-65.
53. Aksoy M, Erdem S, Dincol G. Types of leukemia in chronic benzene poisoning. A study in thirty-four patients. Acta Haematol 1976; 55:65-72.
54. Aksoy M. Malignancies due to occupational exposure to benzene. Am J Indust Med 1985; 7:395-402.
55. Farrow A, Jacobs A, West RR. Myelodysplasia, chemical exposure and other environmental factors. Leukemia 1989; 3:33-35.
56. West RR, Stafford DA, Farrow A, Jacobs A. Occupational and environmental exposures and myelodysplasia: a case control exposure. Leuk Res 1995; 19:127-139.
57. Goldberg H, Lusk E, Moore J, Nowell PC, Besa EC. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosomal patterns and data on patients without hematological disease. Cancer Res 1990; 50:6876-6881.
58. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 1998; 103:189-197.
59. Ido M, Nagata C, Kawakami N, Shimizu H, Yoshida Y, Nomura T, Mizoguchi H. A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 1996; 20:727-731.
60. Nagata C, Shimizu H, Hirashima K, Kakishita E, Fujimura K, Niho Y, Karasawa M, Oguma S, Yoshida Y, Mizoguchi H. Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 1999; 23: 57-62.
61. Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, Brillet JM, Lejeune R, Fenaux P. Occupational and environmental risk factors of the myelodys-plastic syndromes in the north of France. Br J Haematol 2001; 112:927-935.